Document Detail


The financial costs to patients of diagnosing and excluding ectopic pregnancy.
MedLine Citation:
PMID:  23112088     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Health care costs are one of the greatest challenges in modern medicine. In gynaecology, diagnosing and excluding ectopic pregnancy (EP) has been shown to be a financial burden to health services because it commonly requires multiple investigations and hospital visits. However, the full economic costs are not captured by an analysis of health care costs alone. This study therefore aimed to assess the indirect costs to patients of diagnosing and excluding EP.
METHODS: Patients presenting to a Pregnancy Support Centre in a large UK teaching hospital with abdominal pain and/or bleeding and a positive pregnancy test were recruited during the period June 2010-February 2011. Patients were provided with questionnaires to be completed at home and designed to record and quantify costs that they had incurred until a final diagnosis of their condition was made. A cost-description analysis was performed.
RESULTS: 52/203 (26%) recruited patients returned completed questionnaires. The mean cost to patients of diagnosing or excluding EP was £135.13±£51.60 (median £20.70). The main cost drivers identified were hospital visits, holiday cancellations, income loss and household help.
CONCLUSIONS: Quantification of the indirect costs of diagnosing and excluding EP is challenging because it relies on questionnaire feedback from patients at a time when they have suffered from the emotional impact of pregnancy loss. However, initial estimates suggest that such costs are significant due to diagnostic delays. This further highlights the importance of the development of potential biomarkers of EP to allow prompt diagnosis.
Authors:
Holger W Unger; Lisa Starrs; Linda Scott; Hilary O D Critchley; W Colin Duncan; Andrew W Horne
Related Documents :
20410088 - Diet quality in early pregnancy and its effects on fetal growth outcomes: the infancia ...
25013738 - Pregnancy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ...
24141548 - Evidence-based treatment of schistosomiasis in pregnancy.
24971118 - Evaluation of plasma creatine phosphokinase (cpk) level following a single injection of...
16329158 - Use of coptidis rhizoma and foetal growth: a follow-up study of 9,895 pregnancies.
8813308 - Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal n...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-10-30
Journal Detail:
Title:  The journal of family planning and reproductive health care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists     Volume:  39     ISSN:  1471-1893     ISO Abbreviation:  J Fam Plann Reprod Health Care     Publication Date:  2013 Jul 
Date Detail:
Created Date:  2013-06-19     Completed Date:  2013-12-11     Revised Date:  2014-02-20    
Medline Journal Info:
Nlm Unique ID:  101087687     Medline TA:  J Fam Plann Reprod Health Care     Country:  England    
Other Details:
Languages:  eng     Pagination:  197-200     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cost of Illness
Costs and Cost Analysis
Female
Health Expenditures*
Humans
Pregnancy
Pregnancy, Ectopic / diagnosis*,  economics
Questionnaires
Scotland
Grant Support
ID/Acronym/Agency:
G0802808//Medical Research Council; SCD/02//Chief Scientist Office

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Interactions between Artemisinins and other Antimalarial Drugs in Relation to the Cofactor Model-A U...
Next Document:  Role of FGFRL1 and other FGF signaling proteins in early kidney development.